4Filing Date: Sep 17, 2026

Guardant Health (GH)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001666236-26-000024
Total Value$1.17M
Trades4
Insiders1

Transaction Details

Krognes Steve E.
Director·Direct
Sell · Dispose
Common Stock
Shares-1.10K
Price$174.46
Total Value$192.4K
Shares Owned After13.48K
Transaction DateSep 16, 2026
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $173.98 to $174.975. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Krognes Steve E.
Director·Direct
Sell · Dispose
Common Stock
Shares-3.30K
Price$175.42
Total Value$578.9K
Shares Owned After10.18K
Transaction DateSep 16, 2026
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $175.02 to $176.01. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Krognes Steve E.
Director·Direct
Sell · Dispose
Common Stock
Shares-971
Price$177.48
Total Value$172.3K
Shares Owned After7.91K
Transaction DateSep 16, 2026
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $177.08 to $177.945. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Krognes Steve E.
Director·Direct
Sell · Dispose
Common Stock
Shares-1.30K
Price$176.34
Total Value$229.2K
Shares Owned After8.88K
Transaction DateSep 16, 2026
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $176.055 to $176.88. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Post-Transaction Holdings

Krognes Steve E. · Director
SecuritySharesChange
Common Stock13.48K-6.67K (-33.12%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-16 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Krognes Steve E. CIK: 0001666236 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-16 | Code: S (Open market sale) Shares: -1,103 | Price: $174.46 Total Value: $192,431.92 Shares Owned After: 13,477 | Ownership: D (Direct) Footnotes: [F1] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $173.98 to $174.975. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. [Transaction #2] Security: Common Stock Date: 2026-09-16 | Code: S (Open market sale) Shares: -3,300 | Price: $175.42 Total Value: $578,887.98 Shares Owned After: 10,177 | Ownership: D (Direct) Footnotes: [F2] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $175.02 to $176.01. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. [Transaction #3] Security: Common Stock Date: 2026-09-16 | Code: S (Open market sale) Shares: -1,300 | Price: $176.34 Total Value: $229,236.02 Shares Owned After: 8,877 | Ownership: D (Direct) Footnotes: [F3] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $176.055 to $176.88. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. [Transaction #4] Security: Common Stock Date: 2026-09-16 | Code: S (Open market sale) Shares: -971 | Price: $177.48 Total Value: $172,329.78 Shares Owned After: 7,906 | Ownership: D (Direct) Footnotes: [F4] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $177.08 to $177.945. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. --- Footnotes (Complete Index) --- F1: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $173.98 to $174.975. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F2: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $175.02 to $176.01. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F3: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $176.055 to $176.88. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F4: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $177.08 to $177.945. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. --- Signature --- /s/ /s/ John Saia, as attorney-in-fact for Steve Krognes (2026-09-17)

keid analysis is for reference only and does not constitute investment advice.